DEVELOPMENT COST. Hansoh shall bear (i) all costs and expenses in respect of the Development of the Licensed Product for the NMOSD indication, the Viela LCM Indications, and Hansoh Selected Indications in the Territory, including the Fully Burdened Costs of the Licensed Products used for such Development; provided that the costs and expenses for any Global Study for the Licensed Product for a Viela LCM Indication will be calculated in accordance with Section 3.1(b)(ii); and (ii) any and all costs and fees associated with applying for and obtaining Regulatory Approval in the Territory for the Licensed Products. Viela may invoice Hansoh on a [***] for the costs incurred by Viela or Designee, and Hansoh shall pay the amount invoiced within [***] ([***]) [***] after the receipt of any such invoice.
Appears in 2 contracts
Sources: License and Collaboration Agreement (Viela Bio, Inc.), License and Collaboration Agreement (Viela Bio, Inc.)